To further substantiate these findings, we examined the effects of E2F1 activity on the invasive capacity of patient-derived metastatic bladder and breast tumor cell lines using functional invasion assays, western blotting, and PCR analysis. The gene discussed is E2F1; the disease is breast neoplasm.